Skip to main content
Equibles
NVNO logo

NVNO · enVVeno Medical Corp

Track NVNO — free

Use NVNO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NVNO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.01 -0.09 (-1.11%)
Rebalance outlook locked
Market Cap
$5.92M
Shares
682,722
Volume · Oct 5 10.59K Avg daily vol (3M) 23.47K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$8.10 Open$8.11 Day$7.70–8.78 52W close$7.80–33.88 Avg vol 30d25K Short int9K · 1.4% float · 1.0d Short vol73% DataJan 2020–Oct 2026 Filing10-Q · Jul 30

Up next

Latest filing: 10-Q
filed Jul 30, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$186,730
Trailing 12 months
Net income (TTM)
−$15.72M
Trailing 12 months
Revenue growth YoY
+0.6%
Year over year
Operating margin
-24,566.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$21.49M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+15.5%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.4%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −25%
below
Price vs 50-day avg −21%
below
RSI (14) 33
neutral
MACD trend Negative
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −27%
trailing
6-month return −27%
trailing
YTD return −28%
this year
Relative strength −39%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $10 › 200d $11 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.37% of float · ▲ +11.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
17 holders — near 3-yr low, contrarian setup
Squeeze score 33
low risk · 0–100
Fundamentals
Fair
Revenue growth −83%
Y/Y
Gross margin 597%
expanding
EPS growth +26%
Y/Y
Free cash flow $-15.6M
Quant / Vol
risk profile
Very High
Volatility 89%
annualized · 1-yr
Max drawdown −77%
past year
ATR 9.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−25% Bearish
Price vs 50-day avg
−21% Bearish
RSI (14)
33 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $10 › 200d $11 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.37% of float · ▲ +11.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
17 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $8 Now $8 · 1% Range high $34
vs 200-day avg -25% vs 50-day avg -21%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NVNO
enVVeno Medical Corp
this stock
$5.92M — -83.3% — 1.4%
ABT
Abbott Laboratories
 $174.90B -22.2% +5.7% 28.1 1.1%
MDT
Medtronic plc
 $113.38B -10.1% +8.4% 21.8 1.3%
SYK
Stryker Corp
 $104.47B -21.6% +11.2% 28.2 2.0%
BSX
Boston Scientific Corp
 $63.59B -55.3% +12.5% 17.8 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
17
% held
13.0%
Net QoQ
-11.8K sh
Top holder
KINGDON CAPITAL MANAGEMEN…
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Rising
Shares short
9.4K
Days to cover
1.0d
Change
+935 sh
View
Short Volume
Short vol %
73%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
46
Value
$516
As of
Sep 3, 2026
View
Off-Exchange
Off-exchange %
66.0%
Week of
Aug 31, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$31.2K
Net income (FY)
$-19.5M
EPS diluted
$-33.06
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Sep 11, 2026
This year
8
View
Proposed Sales
Value
$123
Shares
11
Filed
Sep 11, 2026
View
Exempt Offerings
Offering
$1.6M
Filed
Aug 4, 2020
View
Earnings & Events
Webcasts
Last webcast
Sep 11, 2026
View

Performance

5D 20D 120D MTD YTD
NVNO -6.6% -27.0% -26.7% +3.9% -27.9%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -6.4% -26.6% -38.9% +2.9% -40.8%
Key facts CIK 1661053 CUSIP 29415J205 Visit website Investor relations